NR5A2 and pancreatic neoplasm: Knockdown of NR5A2 in pancreatic cancer decreased the expression of FGB, TWIST, SNAIL, MMP9, MMP3, MMP2, and Vimentin, as well as increased the expression of the epithelial markers β-catenin and E-cadherin (32).